Skip to main content

Hydroxychloroquine and the Intelligence Murders Investigation

Hydroxychloroquine (HCQ) is an inexpensive antimalarial drug that has been on the World Health Organization's list of essential medicines for decades. During the COVID-19 pandemic it became one of the most publicly contested early-pandemic treatments. This page does not take a position on HCQ's clinical efficacy against COVID-19. It documents the people connected to the drug — manufacturers, advocates, critics, and one billionaire generic-pharmaceutical founder murdered in his home two years before the pandemic — whose stories fall within this investigation's scope.

Image Evidence​

Barry and Honey Sherman, founders of Apotex

A May 2, 2026 social-media post by @LightOnLiberty on X connected the unsolved 2017 murders of Apotex founders Barry and Honey Sherman to the subsequent demonization of hydroxychloroquine during COVID-19. The connection is unverified and is documented here as a circulating claim.

What Hydroxychloroquine Is​

Hydroxychloroquine (sold under brand names including Plaquenil, and as a generic by manufacturers including Apotex under the name Apo-Hydroxyquine) is an antimalarial drug derived from chloroquine. Approved by the FDA in 1955, it has been used continuously for decades to treat:

  • Malaria (prophylaxis and active infection)
  • Systemic lupus erythematosus
  • Rheumatoid arthritis
  • Sjögren's syndrome and related autoimmune conditions

It is on the World Health Organization's List of Essential Medicines. As a generic drug manufactured by multiple companies worldwide, it is inexpensive — typically costing pennies to a few dollars per dose — making it a significant product line for generic-pharmaceutical companies but a low-margin one for brand-name pharmaceutical firms.

The COVID-19 Dispute​

In early 2020, hydroxychloroquine became one of the most publicly contested potential treatments for COVID-19.

DateEvent
March 19, 2020French researcher Didier Raoult published a small open-label study reporting that HCQ combined with azithromycin reduced viral load.
March 20, 2020U.S. President Donald Trump publicly endorsed HCQ as a potential COVID-19 treatment.
March 28, 2020FDA issued an Emergency Use Authorization (EUA) allowing HCQ and chloroquine for hospitalized COVID-19 patients.
May 22, 2020The Lancet published Mehra et al. — a multinational retrospective study claiming HCQ caused increased mortality. WHO halted HCQ trials within days.
June 4, 2020The Lancet retracted the Mehra et al. study after the underlying database from a company called Surgisphere could not be independently verified. The New England Journal of Medicine retracted a related paper the same week.
June 15, 2020FDA revoked the EUA for HCQ in COVID-19 patients, citing later randomized trials.
2020–2026Multiple subsequent studies, meta-analyses, and political-policy disputes continued. The drug's COVID-19 efficacy remains contested in some quarters; consensus medical guidance does not currently recommend HCQ for COVID-19.

This investigation makes no finding on the underlying medical question. What it tracks is whether specific people were silenced, retaliated against, or killed in connection with the dispute.

The Sherman Murders and Apotex​

In December 2017 — roughly two years before the COVID-19 pandemic emerged — Barry Sherman and his wife Honey Sherman were found dead in their Toronto home. Toronto Police initially briefed reporters that a murder-suicide was the leading theory; six weeks later, on January 26, 2018, after the family's privately retained forensic team produced contrary findings, police publicly reclassified the case as a "targeted double homicide." It remains unsolved as of 2026, despite a $10 million CAD privately-funded reward — the largest in Canadian history.

Barry Sherman founded Apotex Inc., Canada's largest pharmaceutical company and one of the world's largest generic drug manufacturers. Apotex produced generic hydroxychloroquine. According to @LightOnLiberty on X (May 2, 2026), Apotex was "Canada's ONLY manufacturer for cheaper and more effective Hydroxychloroquine." The "only" claim is disputed — other generic manufacturers operated in Canada at the time — but Apotex was unquestionably one of Canada's largest producers of generic HCQ and a globally significant supplier.

The social-media speculation links the Sherman murders to subsequent suppression of hydroxychloroquine during COVID-19. No criminal investigation, official inquiry, or peer-reviewed source has substantiated this connection. Toronto Police have made no public statement linking the murders to pharmaceuticals, HCQ, or the pandemic. The motive for the killings remains officially unknown.

The questions raised by the post:

  • Did Apotex's role as a major generic HCQ producer matter to whoever ordered the killings?
  • Why has the case gone unsolved more than eight years despite a $10M CAD reward?
  • Is the timing — two years before HCQ became contested in COVID-19 — coincidence?

These questions remain open. Readers should weigh them against the absence of any corroborating evidence.

See: Barry Sherman profile | COVID-19 topic page

Additional Account from a GTA Resident​

A contributor to this investigation, who lived in the Greater Toronto Area at the time of the Sherman killings and later returned to Florida, submitted the following recollection (May 2, 2026):

"I was living in the GTA at the time of this double murder. They were rare up there then. When COVID hit, I remembered the case. I was back home in Florida by then.

The 'known culprit' had the matter SEALED by the Court.

Now Canada will arrest you for possession on these drugs — it undercuts their Big Pharma."

This is a personal recollection and a set of circulating claims, not findings of this investigation. For accuracy:

  • The "known culprit" / sealed-court claim: Toronto Police have publicly identified no suspect by name in the Sherman case as of 2026. A "person of interest" video was released in 2021. Sealing orders have been issued in Sherman-related civil and probate proceedings — most notably contested by the Toronto Star in Sherman Estate v. Donovan, 2021 SCC 25, where the Supreme Court of Canada ruled against blanket sealing of the estate file. Search-warrant information-to-obtain (ITO) materials in the homicide investigation reportedly remain sealed at the request of police and the Crown for ongoing-investigation reasons. No public court order names any "culprit." The contributor's framing is preserved as a stated claim, not as a finding.
  • The Canadian HCQ possession claim: As of 2026, hydroxychloroquine is a prescription-only medication in Canada under the Food and Drugs Act (Health Canada's Prescription Drug List). It is not scheduled under the Controlled Drugs and Substances Act. With a valid prescription, possession is lawful. During COVID-19, Health Canada and several provincial pharmacy regulatory colleges issued guidance restricting HCQ prescribing for COVID-19 outside clinical trials — for example, the Ontario College of Pharmacists and the College of Physicians and Surgeons of Ontario both issued such guidance in spring 2020. The investigation is not aware of a general criminal-arrest power for HCQ possession in Canada. The contributor's "Big Pharma" framing is documented as their stated interpretation, not as an investigative conclusion.

The recollection is preserved because the contributor was geographically and temporally proximate to the Sherman case and personally noted the COVID-era thematic connection.

Generic Manufacturers and Pricing​

Hydroxychloroquine has been off-patent for decades. Multiple generic manufacturers around the world produce it, including:

  • Apotex (Canada) — Apo-Hydroxyquine. Founded by Barry Sherman.
  • Teva Pharmaceutical Industries (Israel/global) — major generic producer worldwide.
  • Mylan / Viatris (U.S./global) — major generic producer.
  • Sandoz (Novartis) (Switzerland/global) — major generic producer.
  • Sun Pharmaceutical (India) — large global supplier; India has been one of the world's largest exporters of HCQ.
  • Zydus Cadila (India) — large generic producer.
  • Ipca Laboratories (India) — was a primary supplier to U.S. wholesalers in 2020.

The drug's low cost — pennies per dose at generic-manufacturer level — has been cited by critics of the COVID-19 EUA revocation as a financial reason brand-name pharmaceutical firms had little incentive to support its use; this is contested by other observers who point to the published clinical-trial data.

Documented Retaliation Cases​

This investigation tracks documented retaliation against doctors, scientists, or whistleblowers connected to the hydroxychloroquine dispute. As cases are added, they should be linked here.

PersonYearStatusConnection
Barry Sherman2017DeceasedApotex founder, major generic HCQ producer. Unsolved targeted double homicide. Linked by social-media speculation to the COVID-19 HCQ dispute; no investigative finding supports the link.
Brandy Vaughan2020DeceasedFormer Merck sales rep and Vioxx whistleblower who founded Learn The Risk. Documented years of professional-grade home intrusions. Found dead at 44 of sudden blood clots. Had publicly predicted her death and named pharmaceutical-industry retaliation.

If you are aware of additional documented cases — especially of physicians or scientists who reported professional or physical retaliation tied to advocating for or against HCQ — please consider submitting them.

What This Page Does Not Claim​

  • It does not claim hydroxychloroquine was an effective COVID-19 treatment, nor that it was not.
  • It does not claim Barry Sherman's murder was caused by his role at Apotex.
  • It does not claim any specific intelligence service was involved in any of the deaths listed.
  • It does not claim the FDA, WHO, The Lancet, or any specific government agency acted in bad faith on the EUA decisions.

It documents people, deaths, and circulating claims — and applies the project's strict attribution and defamation rules to each.

See Also​

Sources​

This information was built by Grok and Claude AI research.

Last updated on